eXmoor Pharma is a technical and strategic consultancy specialising in cell and gene therapies (ATMPs) and biopharmaceuticals.
eXmoor Pharma has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in May 2023.
eXmoor Pharma's investors include MVM Life Science Partners, Kineticos Ventures.
eXmoor Pharma is headquartered in Bristol, United Kingdom.
eXmoor Pharma is a technical and strategic consultancy specialising in cell and gene therapies (ATMPs) and biopharmaceuticals.
eXmoor Pharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"eXmoor Pharma — Funding & Investors." VCBacked, May 30, 2023, https://www.vcbacked.co/company/exmoor-pharma. Accessed October 30, 2026.
VCBacked. (2023). eXmoor Pharma — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/exmoor-pharma
{{cite web |title=eXmoor Pharma — Funding & Investors |url=https://www.vcbacked.co/company/exmoor-pharma |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated